The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, M. J.
Right arrow Articles by Richardson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, M. J.
Right arrow Articles by Richardson, B.
The Journal of Immunology, 2004, 172: 3652-3661.
Copyright © 2004 by The American Association of Immunologists

Demethylation of Promoter Regulatory Elements Contributes to Perforin Overexpression in CD4+ Lupus T Cells1

Mariana J. Kaplan2,*, Qianjin Lu2,*, Ailing Wu*, John Attwood* and Bruce Richardson3,*,{dagger}

* Department of Medicine, University of Michigan, and {dagger} Department of Medicine, Ann Arbor Veterans Affairs Medical Center, Ann Arbor, MI 48109

Inhibiting DNA methylation in CD4+ T cells causes aberrant gene expression and autoreactive monocyte/macrophage killing in vitro, and the hypomethylated cells cause a lupus-like disease in animal models. Similar decreases in T cell DNA methylation occur in idiopathic lupus, potentially contributing to disease pathogenesis. The genes affected by DNA hypomethylation are largely unknown. Using DNA methylation inhibitors and oligonucleotide arrays we have identified perforin as a methylation-sensitive gene. Our group has also reported that DNA methylation inhibitors increase CD4+ T cell perforin by demethylating a conserved methylation-sensitive region that is hypomethylated in primary CD8+ cells, which express perforin, but is largely methylated in primary CD4+ cells, which do not. As lupus T cells also have hypomethylated DNA and promiscuously kill autologous monocytes/macrophages, we hypothesized that perforin may be similarly overexpressed in lupus T cells and contribute to the monocyte killing. We report that CD4+ T cells from patients with active, but not inactive, lupus overexpress perforin, and that overexpression is related to demethylation of the same sequences suppressing perforin transcription in primary CD4+ T cells and demethylated by DNA methylation inhibitors. Further, the perforin inhibitor concanamycin A blocks autologous monocyte killing by CD4+ lupus T cells, suggesting that the perforin is functional. We conclude that demethylation of specific regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. Our results also suggest that aberrant perforin expression in CD4+ lupus T cells may contribute to monocyte killing.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Q. Lu, A. Wu, L. Tesmer, D. Ray, N. Yousif, and B. Richardson
Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus
J. Immunol., November 1, 2007; 179(9): 6352 - 6358.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Gorelik, J. Y. Fang, A. Wu, A. H. Sawalha, and B. Richardson
Impaired T Cell Protein Kinase C{delta} Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus
J. Immunol., October 15, 2007; 179(8): 5553 - 5563.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Balada, J. Ordi-Ros, S. Serrano-Acedo, L. Martinez-Lostao, and M. Vilardell-Tarres
Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients
J. Leukoc. Biol., June 1, 2007; 81(6): 1609 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ding, H. Mehta, W. J. McCune, and M. J. Kaplan
Aberrant Phenotype and Function of Myeloid Dendritic Cells in Systemic Lupus Erythematosus
J. Immunol., November 1, 2006; 177(9): 5878 - 5889.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Ballestar, M. Esteller, and B. C. Richardson
The epigenetic face of systemic lupus erythematosus.
J. Immunol., June 15, 2006; 176(12): 7143 - 7147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Denny, P. Chandaroy, P. D. Killen, R. Caricchio, E. E. Lewis, B. C. Richardson, K.-D. Lee, J. Gavalchin, and M. J. Kaplan
Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus
J. Immunol., February 15, 2006; 176(4): 2095 - 2104.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Lu, A. Wu, and B. C. Richardson
Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs
J. Immunol., May 15, 2005; 174(10): 6212 - 6219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.